openPR Logo
Press release

Gastroparesis Drugs Market - key vendors in emerging countries are expected to provide lucrative opportunities for the market expansion during the forecast period

04-18-2019 08:41 AM CET | Health & Medicine

Press release from: Allied Market Research

Gastroparesis Drugs Market

Gastroparesis Drugs Market

Gastroparesis Drugs Market was valued at $4,667 million in 2016, and is projected to reach $6,486 million at a CAGR of 4.7% from 2017 to 2023.

Gastroparesis affects the normal spontaneous movement of the muscles of stomach and interferes with the normal digestion, thus causing nausea, vomiting, and problems related with blood sugar levels & nutrition. Gastroparesis is caused due to diabetes or can develop after surgery. Recently, advanced drugs such as metoclopramide, erythromycin, antiemetics, and others are developed to treat gastroparesis.

The major factors that drive the growth of the global gastroparesis drugs market are rise in number of surgeries that may lead to postoperative gastroparesis, increase in diabetic population, introduction of novel drugs, and surge in geriatric population. However, side effects associated with gastroparesis drugs and time-consuming regulatory approvals are expected to restrain the market growth. Conversely, huge untapped market potential in the emerging countries, such as China and India, and development of novel gastroparesis drugs are expected to provide lucrative opportunities to the market players.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/4153

The prokinetic agents segment occupied the largest share in 2016, owing to the high usage, applicability, and availability of prokinetic agents for treating gastroparesis. Furthermore, the botulinum toxin injection segment is expected to grow at the highest CAGR of 5.6% from 2017 to 2023, and is anticipated to continue its dominance during the forecast period. The utilization rate of gastroparesis drugs for idiopathic gastroparesis is high, however post-surgical gastroparesis segment is expected to grow at a CAGR of 5.2% during the forecast period. This is attributed to increase in incidence of various types of surgeries, such as transplantation, which result in postsurgical gastroparesis.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/4153

Key findings of the Gastroparesis Drugs Market:
• Prokinetic agents segment accounted for more than four-fifths share of the global gastroparesis drugs market in 2016.
• Botulinum toxin injection segment is expected to grow at a CAGR of 5.6% from 2017 to 2023.
• Idiopathic gastroparesis segment accounted for around 34.9% share of the global gastroparesis drugs market in 2016.
• Hospitals accounted for nearly two-fifths share of the global gastroparesis drugs market in 2016.
• Pharmacies segment is expected to grow at a CAGR of 5.0% from 2017 to 2023

North America was the leading revenue contributor to the global gastroparesis drugs market, accounting for nearly one-third of the global market. This is attributed to the early approval of gastroparesis drugs and high use of these drugs due to rise in incidence of gastroparesis. However, Asia-Pacific is expected to grow at the highest CAGR of 5.5% during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness toward gastroparesis drugs.

Access Full Summery @ https://www.alliedmarketresearch.com/gastroparesis-drugs-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gastroparesis Drugs Market - key vendors in emerging countries are expected to provide lucrative opportunities for the market expansion during the forecast period here

News-ID: 1708393 • Views: 304

More Releases from Allied Market Research

U.S. Surplus Lines Insurance Market Size Projected to Hit $125.9 Billion by 2027 …
According to a recent report published by Allied Market Research, titled, "U.S. Surplus Lines Insurance Market by Coverage, Distribution Model, and Application: Country Opportunity Analysis and Industry Forecast, 2020-2027," the market was valued at $52.1 billion in 2019, and the U.S. surplus lines insurance market size is projected to reach $125.9 billion by 2027, growing at a CAGR of 15.2% from 2020 to 2027. Some of the major players operating in
Reed Sensor Market 2019–2026: Revenue Projections and Industry Insights | Stan …
Allied Market Research published the latest report, titled "Reed Sensor Market by Type (Dry-Reed Sensor, Mercury-Wetted Reed Sensor) and Application (Automotive, Transportation, Consumer Electronics, Robotics & Automation, Telecommunications, Healthcare, Construction, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026." According to the report, reed sensor market is expected to witness significant growth during the forecast period due to surge in need for technological advancements in the sensors. The emergence of high-tech
Umbrella Market 2020 to Witness a Pronounce Growth During COVID-19 Crisis with D …
Umbrella also is known as parasol is an object used for protection against rain and sunlight. Umbrellas are usually designed for protection from rain whereas parasol is specifically designed and used to block the sunlight. Umbrellas are hand-held portable devices which come in different sizes, shapes, colors, and designs. These have been used since the seventeenth century and are considered as an essential accessory by most of the people. Canopy,
Forage Seed Market Size, Industry Analysis by Leading Key Players, Development a …
The global Forage Seed Market was valued at $11,683 million in 2015 and is projected to reach $20,646 million by 2022, growing at a CAGR of 8.50% from 2016 to 2022. In 2015, the alfalfa product segment held approximately more than one-fourth of the total market. Forage seeds are the edible parts of plants widely utilized for livestock feeding. Alfalfa, clover, chicory, ryegrass, lablab, and fescue are some of the popular

All 5 Releases


More Releases for Gastroparesis

Develop business strategies Of Diabetic Gastroparesis - Pipeline Review, H1 2018
"The Report Diabetic Gastroparesis - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Diabetic Gastroparesis Market Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Gastroparesis - Pipeline Review, H1 2018, provides an overview of the Diabetic Gastroparesis (Gastrointestinal) pipeline landscape. Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1581026 Gastroparesis is a long-term complication of diabetes
Diabetic Gastroparesis-Pipeline Review H1 2017
ReportsWeb.com has announced the addition of the “Diabetic Gastroparesis-Pipeline Review H1 2017” this report provides an overview of the Diabetic Gastroparesis-Pipeline landscape.  Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Gastroparesis - Pipeline Review, H1 2017, provides an overview of the Diabetic Gastroparesis (Gastrointestinal) pipeline landscape. Gastroparesis is a long-term complication of diabetes that involves the stomach and affects digestion. Prolonged high blood sugar levels can damage nerves in many parts
Gastroparesis Drugs Market, Growing $6,486 Million By 2023
The global gastroparesis market was valued at $4,667 million in 2016, and is projected to reach $6,486 million at a CAGR of 4.7% from 2017 to 2023. Gastroparesis is a medical condition of the stomach, which affects the normal spontaneous movement of the muscles of the stomach. It restricts the normal digestion, causes vomiting, and problems related with blood sugar levels & nutrition. Various medications or drugs are prescribed to
Diabetic Gastroparesis - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Diabetic Gastroparesis - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Gastroparesis - Pipeline Review, H2 2017, provides an overview of the Diabetic Gastroparesis (Gastrointestinal) pipeline landscape. Gastroparesis is a long-term complication of diabetes that involves the stomach and affects digestion. Prolonged high blood sugar levels
Gastroparesis Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, Gastroparesis Global Clinical Trials Review, H2, 2017" provides an overview of Gastroparesis clinical trials scenario. This report provides top line data relating to the clinical trials on Gastroparesis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status
Diabetic Gastroparesis - Pipeline Market Research Report, 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Diabetic Gastroparesis - Pipeline Insight, 2017”. This report provides comprehensive insights about pipeline drugs across this Diabetic Gastroparesis. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Diabetic Gastroparesis. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1214082 This report provides information on the therapeutic development for